Evidence map›Paper›PMID 39081682›Full record

ArticleFrontiers in nutrition2024

Reformulating ice cream to improve postprandial glucose response: an opportunity for industry to create shared value.

Ebaa Al-Ozairi, Yousef Mandani, Ghanima Alfaleh, Jincy Raj, Shadan Alshammari, Carel W Le Roux

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ebaa Al-OzairiClinical Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait, Kuwait.
Yousef MandaniClinical Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait, Kuwait.
Ghanima AlfalehClinical Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait, Kuwait.
Jincy RajClinical Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait, Kuwait.
Shadan AlshammariClinical Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait, Kuwait.
Carel W Le RouxClinical Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait, Kuwait.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultra-processed foods are associated with metabolic dysfunction and driving chronic diseases. The Metabolic Matrix is a tool used to reformulate products to promote positive metabolic outcomes. The Kuwait Danish Dairy Company (KDD) has used this tool to develop a no-added-sugar products. This clinical trial tested the glycaemic response of a no-added-sugar ice cream in individuals with type 2 diabetes. The hypothesis was that the no-added-sugar ice cream would have a substantially better postprandial glycemic response than conventional ice cream in patients with type 2 diabetes. In this randomized cross over designed study, postprandial glycemic response was measured after 300 grams of no-added-sugar ice cream or normal ice cream was consumed. Despite similar composition and palatability, the postprandial responses were better with the no-added sugar ice cream, albeit that the natural sugar in the product still resulted in a marked postprandial glycaemic response. This finding emphasizes the necessity of clearly communicating to both patients and healthcare professionals that "no-added-sugar" does not equate to "zero total sugar." The path to improved metabolic health involves not only product improvement but also transparent messaging to enable informed dietary choices. Reformulation resulting in palatable no-added sugar products provides an opportunity for companies to Create Shared Value by addressing the important social problems such as obesity and type 2 diabetes, by creating scalable solutions, that are profitable.

Indexed as

creating shared valuemetabolic matrixno-added sugar ice creampostprandial glucose responsestype 2 diabetes

Identifiers

PMID39081682
PMCPMC11288177

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.